CompletedNCT02507206
DAR-0100A for Attention and Memory in Schizotypal Personality
About this title
Read the official source — NCT02507206Medication studyAges 18–65United StatesPersonality disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateApril 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 120
- Sponsor
- Antonia New
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02507206
- Official title
Show the full official title
A D1 Agonist For Working Memory Enhancement In The Schizophrenia Spectrum
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Registry details
Registry conditions (original wording)
Schizotypal Personality Disorder; SPD
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Antonia New.
Did this study involve medication?
Yes. The study involved medication, including DAR 0-100A and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
